No­var­tis un­veils a new glob­al R&D struc­ture, cre­at­ing cen­ters in Cam­bridge, MA and Basel

No­var­tis is un­veil­ing some big new changes to its R&D or­ga­ni­za­tion to­day, fo­cus­ing heav­i­ly on new re­search op­er­a­tions based in Cam­bridge, MA as well as Basel while shut­ter­ing two units in Chi­na and Switzer­land and re­lo­cat­ing an­oth­er from Sin­ga­pore to the Bay Area.

Hot on the heels of its stun­ning de­ci­sion to shut down its cell and gene ther­a­py group while lay­ing off 120, the com­pa­ny plans to tell em­ploy­ees at town hall meet­ings lat­er to­day that it is es­tab­lish­ing a new ear­ly-stage op­er­a­tion along with the cre­ation of two new re­search cen­ters. Here’s a quick look at the over­all plan as out­lined by No­var­tis in re­sponse to a query from End­points News:

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.